The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126286631 12628663 1 I 20160304 20160808 20160808 PER US-JAZZ-2016-US-004486 JAZZ 0.00 M Y 0.00000 20160808 US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126286631 12628663 1 PS XYREM SODIUM OXYBATE 1 Oral 3 G, BID 21196 3 G ORAL SOLUTION
126286631 12628663 2 SS XYREM SODIUM OXYBATE 1 Oral 3.75 G, BID 21196 3.75 G ORAL SOLUTION
126286631 12628663 3 SS XYREM SODIUM OXYBATE 1 Oral 4.5 G, BID 21196 4.5 G ORAL SOLUTION
126286631 12628663 4 SS WELLBUTRIN BUPROPION HYDROCHLORIDE 1 300 MG, UNK 0 300 MG TABLET
126286631 12628663 5 SS WELLBUTRIN BUPROPION HYDROCHLORIDE 1 450 MG, UNK 0 450 MG TABLET
126286631 12628663 6 C LIDODERM LIDOCAINE 1 UNK U 0 PATCH
126286631 12628663 7 C ADDERALL AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE 1 UNK U 0 TABLET
126286631 12628663 8 C AMBIEN ZOLPIDEM TARTRATE 1 UNK U 0 TABLET
126286631 12628663 9 C ANDRODERM TESTOSTERONE 1 UNK U 0 PATCH
126286631 12628663 10 C CLONAZEPAM. CLONAZEPAM 1 UNK U 0 TABLET
126286631 12628663 11 C FINASTERIDE. FINASTERIDE 1 UNK U 0 TABLET
126286631 12628663 12 C TEMAZEPAM. TEMAZEPAM 1 UNK U 0 CAPSULE
126286631 12628663 13 C VITAMIN D CHOLECALCIFEROL 1 UNK U 0
126286631 12628663 14 C VYVANSE LISDEXAMFETAMINE DIMESYLATE 1 UNK U 0 CAPSULE

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126286631 12628663 1 Narcolepsy
126286631 12628663 2 Cataplexy
126286631 12628663 4 Depression
126286631 12628663 6 Product used for unknown indication
126286631 12628663 7 Product used for unknown indication
126286631 12628663 8 Product used for unknown indication
126286631 12628663 9 Product used for unknown indication
126286631 12628663 10 Product used for unknown indication
126286631 12628663 11 Product used for unknown indication
126286631 12628663 12 Product used for unknown indication
126286631 12628663 13 Product used for unknown indication
126286631 12628663 14 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
126286631 12628663 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126286631 12628663 Depression
126286631 12628663 Therapeutic response decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126286631 12628663 1 201206 2012 0
126286631 12628663 2 201207 2015 0
126286631 12628663 3 201503 0
126286631 12628663 6 20150806 20160101 0
126286631 12628663 7 20140123 20151201 0
126286631 12628663 8 20160101 0
126286631 12628663 12 20160101 0